{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Shuttle Pharmaceuticals Holdings, Inc."},"Symbol":{"label":"Symbol","value":"SHPH"},"Address":{"label":"Address","value":"ONE RESEARCH COURT,SUITE 450, ROCKVILLE, Maryland, 20850, United States"},"Phone":{"label":"Phone","value":"+1 240 403-4212"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy."},"CompanyUrl":{"label":"Company Url","value":"https://www.shuttlepharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anatoly Dritschilo","title":"Chairman & Chief Executive Officer"},{"name":"Mira Jung","title":"Chief Scientific Officer-Biology"},{"name":"Peter Dritschilo","title":"President & Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}